UCB, Inc. v. Mylan Technologies Inc., No. 21-2336 (Fed. Cir. Apr. 12, 2023)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Please make the following change to the caption in the opinion and judgment issued April 12, 2023, and the order granting an extension of time issued May 8, 2023:1 UCB, INC., UCB PHARMA GMBH, LTS LOHMANN THERAPIE-SYSTEME AG, Plaintiffs-Appellants v. ACTAVIS LABORATORIES UT, INC., Defendant-Appellee ______________________ 2021-1924 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:19 -cv-00474-KAJ, Circuit Judge Kent A. Jordan.